Literature DB >> 23426265

MicroRNA-34a regulates cardiac ageing and function.

Reinier A Boon1, Kazuma Iekushi, Stefanie Lechner, Timon Seeger, Ariane Fischer, Susanne Heydt, David Kaluza, Karine Tréguer, Guillaume Carmona, Angelika Bonauer, Anton J G Horrevoets, Nathalie Didier, Zenawit Girmatsion, Peter Biliczki, Joachim R Ehrlich, Hugo A Katus, Oliver J Müller, Michael Potente, Andreas M Zeiher, Heiko Hermeking, Stefanie Dimmeler.   

Abstract

Ageing is the predominant risk factor for cardiovascular diseases and contributes to a significantly worse outcome in patients with acute myocardial infarction. MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing. We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426265     DOI: 10.1038/nature11919

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  36 in total

1.  Production and purification of recombinant adeno-associated virus.

Authors:  W W Hauswirth; A S Lewin; S Zolotukhin; N Muzyczka
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2.

Authors:  J Karlseder; D Broccoli; Y Dai; S Hardy; T de Lange
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

Review 3.  MicroRNAs in the p53 network: micromanagement of tumour suppression.

Authors:  Heiko Hermeking
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

4.  Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells.

Authors:  Reinier A Boon; Carmen Urbich; Ariane Fischer; Ruud D Fontijn; Florian H Seeger; Masamichi Koyanagi; Anton J G Horrevoets; Stefanie Dimmeler
Journal:  Eur Heart J       Date:  2010-05-21       Impact factor: 29.983

Review 5.  Pervasive roles of microRNAs in cardiovascular biology.

Authors:  Eric M Small; Eric N Olson
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

6.  Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.

Authors:  Bianca C Bernardo; Xiao-Ming Gao; Catherine E Winbanks; Esther J H Boey; Yow Keat Tham; Helen Kiriazis; Paul Gregorevic; Susanna Obad; Sakari Kauppinen; Xiao-Jun Du; Ruby C Y Lin; Julie R McMullen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-09       Impact factor: 11.205

7.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

8.  Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches.

Authors:  Junya Takagawa; Yan Zhang; Maelene L Wong; Richard E Sievers; Neel K Kapasi; Yan Wang; Yerem Yeghiazarians; Randall J Lee; William Grossman; Matthew L Springer
Journal:  J Appl Physiol (1985)       Date:  2007-03-08

9.  MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure.

Authors:  Geert C van Almen; Wouter Verhesen; Rick E W van Leeuwen; Mathijs van de Vrie; Casper Eurlings; Mark W M Schellings; Melissa Swinnen; Jack P M Cleutjens; Marc A M J van Zandvoort; Stephane Heymans; Blanche Schroen
Journal:  Aging Cell       Date:  2011-05-25       Impact factor: 9.304

10.  BRCA1 is an essential regulator of heart function and survival following myocardial infarction.

Authors:  Praphulla C Shukla; Krishna K Singh; Adrian Quan; Mohammed Al-Omran; Hwee Teoh; Fina Lovren; Liu Cao; Ilsa I Rovira; Yi Pan; Christine Brezden-Masley; Bobby Yanagawa; Aanika Gupta; Chu-Xia Deng; John G Coles; Howard Leong-Poi; William L Stanford; Thomas G Parker; Michael D Schneider; Toren Finkel; Subodh Verma
Journal:  Nat Commun       Date:  2011-12-20       Impact factor: 14.919

View more
  311 in total

1.  Systems analysis reveals down-regulation of a network of pro-survival miRNAs drives the apoptotic response in dilated cardiomyopathy.

Authors:  Ruth Isserlin; Daniele Merico; Dingyan Wang; Dajana Vuckovic; Nicolas Bousette; Anthony O Gramolini; Gary D Bader; Andrew Emili
Journal:  Mol Biosyst       Date:  2014-10-31

Review 2.  Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Authors:  Leonne E Philippen; Ellen Dirkx; Jan B M Wit; Koos Burggraaf; Leon J de Windt; Paula A da Costa Martins
Journal:  Mol Ther       Date:  2015-07-28       Impact factor: 11.454

Review 3.  The Aging Heart.

Authors:  Ying Ann Chiao; Peter S Rabinovitch
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-01       Impact factor: 6.915

Review 4.  Recent insights into endothelial control of leukocyte extravasation.

Authors:  Peter L Hordijk
Journal:  Cell Mol Life Sci       Date:  2016-01-21       Impact factor: 9.261

5.  MicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death.

Authors:  Dan Jiao; Huan Zhang; Ziping Jiang; Wenlin Huang; Zhuo Liu; Zhaohui Wang; Yonggang Wang; Hao Wu
Journal:  J Mol Med (Berl)       Date:  2018-07-21       Impact factor: 4.599

Review 6.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

Review 7.  Regulation of SIRT1 by microRNAs.

Authors:  Sung-E Choi; Jongsook Kim Kemper
Journal:  Mol Cells       Date:  2013-11-06       Impact factor: 5.034

Review 8.  miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Authors:  Paige E Bennett; Lynne Bemis; David A Norris; Yiqun G Shellman
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

Review 9.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 10.  The biological functions of miRNAs: lessons from in vivo studies.

Authors:  Joana A Vidigal; Andrea Ventura
Journal:  Trends Cell Biol       Date:  2014-12-04       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.